Form D · Biotechnology
CytomX Therapeutics, Inc.
South San Francisco, CA · CIK 0001501989
Offering snapshot reported Aug 17, 2023 · SEC filing
- Reported sold
- $30M Offering amount: $30M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 29, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 17, 2023 | Initial | $30,000,000 | No comparison | 4 | SEC filing |
| Jun 25, 2015 | Initial | $69,999,999 | No comparison | 33 | SEC filing |
| Jan 6, 2015 | Initial | $16,499,999 | No comparison | 4 | SEC filing |
| Aug 10, 2012 | Initial | $12,599,999 | No comparison | 3 | SEC filing |
| Sep 28, 2010 | Initial | $524,994 | No comparison | 19 | SEC filing |
| Sep 28, 2010 | Initial | $10,000,000 | No comparison | 2 | SEC filing |
| Sep 28, 2010 | Initial | $652,903 | No comparison | 1 | SEC filing |
| Sep 28, 2010 | Initial | $102,097 | No comparison | 1 | SEC filing |
| Sep 28, 2010 | Initial | $2,660,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-489946
Source: Form D, filed Aug 17, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan Ashworth | Director |
| Marcia Belvin | Executive |
| Wayne Chu | Executive |
| Neil Exter | Director |
| Halley Gilbert | Director |
| Frederick W. Gluck | Director |
| Alan Heeger | Director |
| Charles Homcy | Director |
| Hoyoung Huh | Director |
| Rachel Humphrey | Director |
| Elaine Jones | Director |
| Jeff Landau | Executive |
| Sean Mc Carthy | Director, Executive |
| James Meyers | Director |
| Mani Mohindru | Director |
| Chris Ogden | Executive |
| Fletcher Payne | Executive |
| Michael E. Pfau | Executive |
| Lloyd Rowland | Executive |
| Tim Shannon | Director |
| Nancy Stagliano | Director, Executive |
| Gary Wilcox | Director |
| Matthew Young | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
151 Oyster Point Blvd. Suite 400
South San Francisco, CA, 94080
South San Francisco, CA, 94080